BioSpace News Archive

Drug Development

XBiotech Announces First Patient Enrolled in Placebo-Controlled Clinical Study Evaluating Its anti-IL-1⍺ Therapy Bermekimab in Patients with Atopic Dermatitis (Eczema)

Chaired by award-winning dermatologist Seth B. Forman, MD, of ForCare Medical Group in Tampa, FL, the study will assess weekly bermekimab therapy to reduce inflammatory skin lesions, itch, and pain in patients suffering from eczema.

November 12, 2019
·
6 min read
BioForest

Dr. Gregory Jantz Explains Signs and Symptoms of Depression and Anxiety for the Holidays

Guidance for professionals and individuals who are struggling with depression and anxiety.

November 12, 2019
·
5 min read
Drug Development

Eiger Announces Peginterferon Lambda - Lonafarnib Combination Interim Results in Hepatitis Delta Virus (HDV) Infection from Phase 2 LIFT Study During Late-Breaker Oral Presentation at AASLD 2019

53% of Patients Achieve Undetectable or BLOQ HDV RNA at Week 24

November 12, 2019
·
8 min read
Drug Development

DURECT Corporation Announces Positive Results from the Phase 2a Clinical Trial of DUR-928 in Alcoholic Hepatitis Patients in a Late-Breaking Presentation at The Liver Meeting®

Live Webcast of Data Presentation and Discussion by KOL, Tarek I. Hassanein, M.D. at Noon ET on Tuesday, November 12, 2019

November 12, 2019
·
12 min read
BioCapital

BlackSky Secures $50M in Funding from Intelsat

Creates First Industry Relationship to Pair Earth Observation with Global Communications Infrastructure

November 12, 2019
·
4 min read
BioCapital

Excella Announces Spin-Off of NextUp Solutions Inc. to Expand World-Class Training and Internship Units

Continues focus on transformative solutions while spin-off brings award-winning learning programs to national audience

November 12, 2019
·
3 min read
Job Trends

Denver Surgeon Launches EVEXIAS™ Medical Denver, Becomes Colorado’s Exclusive EvexiPEL® Provider

The owner of Denver Vein Center, a top vein treatment center in Colorado since 2004, announces a new, integrated approach to patient health care with the launch of EVEXIAS Medical Denver - Colorado’s exclusive provider of EvexiPEL™,

November 12, 2019
·
3 min read
Job Trends

W. L. Gore & Associates To Reveal New Gender Insights From Real-world Aortic Data At 2019 VEITHsymposium

Four presentations will highlight data from one of the largest industry-sponsored registries of aortic stent grafts

November 12, 2019
·
3 min read
Deals

Dr. Shafer of Shafer Plastic Surgery and Laser Center Announces the Acquisition of the Vbeam® Prima Laser SystemThe new Vbeam Prima platform takes Candela’s “gold standard” 595 nm Pulsed Dye Laser (PDL) to the next level

Dr. David Shafer of Shafer Plastic Surgery and Laser Center in midtown Manhattan, announces the acquisition of the Vbeam® Prima™ Laser System by Candela, an advanced 595 nm pulsed dye laser (PDL).

November 12, 2019
·
3 min read
Resverlogix to Hold BETonMACE Conference Call and Webcast on November 18, 2019The Presentation of Additional BETonMACE Results to Supplement AHA Late Breaking Science Session held on November 16, 2019

Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX) today announces that it has scheduled a conference call and webcast to supplement the presentation of BETonMACE results to be made during the American Heart Association’s (“AHA”) annual conference.

November 12, 2019
·
3 min read